S5 Ep 2 The Utility of Blood-Based Biomarkers in Cognitive Assessment

In this special bonus episode, familiar guest Dr Steph Daly returns for a cameo conversation with Hilton. Drawing on her involvement in an ongoing clinical trial, Steph shares emerging insights into the role of blood-based biomarkers in assessing people presenting with cognitive symptoms in general practice, and what this evolving evidence could mean for future clinical pathways. Show Notes Alzheimer's Association® Clinical Practice Guideline: Integrating Blood-Based Biomarkers in Alzheimer's Disease Specialized Care Roche Elecsys Phospho-Tau (181P) Product Information - JAMA Network - Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care - Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care | Neurology | JAMA | JAMA Network ADNeT - Blood Based Biomarker Study - enquiry information for GPs in Melbourne, Adelaide and Newcastle - Blood-Based Biomarkers for Alzheimer's Disease in Primary Care: A Before and After Study - Australian Dementia Network Dementia Training Australia – General Practitioners Hub - RACGP Quick Log for GP CPD -

You can listen to S5 Ep 2 The Utility of Blood-Based Biomarkers in Cognitive Assessment online on Radio and Podcast. Open the player on this page to stream the available audio.

S5 Ep 2 The Utility of Blood-Based Biomarkers in Cognitive Assessment is an episode from Dementia in Practice by Margaret Winbolt.

This episode is 40:45 long.

This episode was published on Mar 18, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Dementia in Practice when more episodes are available from the podcast feed.